Global atopic dermatitis drugs market 1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Atopic Dermatitis Drugs Market Size, by Market Value (US$ Mn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7.Key Trends in Global Atopic Dermatitis Drugs Market 5. Global Atopic Dermatitis Drugs Market Analysis and Forecast 5.1. Global Atopic Dermatitis Drugs Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By Therapy 6.1. Introduction and Definition 6.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 6.3. Global Atopic Dermatitis Drugs Market Size (US$ Mn) Forecast, By Therapy 6.4. Global Atopic Dermatitis Drugs Market Analysis, By Therapy 6.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By Therapy 6.6. Key Trends 6.6.1. Key Developments 7. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By Route of Administration 7.1. Introduction and Definition 7.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 7.3. Global Atopic Dermatitis Drugs Market Size (US$ Mn) Forecast, By Route of Administration 7.4. Global Atopic Dermatitis Drugs Market Analysis, By Route of Administration 7.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By Route of Administration 7.6. Key Trends 7.6.1. Key Developments 8. Global Atopic Dermatitis Drugs Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Global Atopic Dermatitis Drugs Market Value Share Analysis, By End User 8.3. Global Atopic Dermatitis Drugs Market Size (US$ Mn) Forecast, By End User 8.4. Global Atopic Dermatitis Drugs Market Analysis, By End User 8.5. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, By End User 8.6. Key Trends 8.6.1. Key Developments 9. Global Atopic Dermatitis Drugs Market Analysis, by Region 9.1. Global Atopic Dermatitis Drugs Market Value Share Analysis, by Region 9.2. Global Atopic Dermatitis Drugs Market Size (US$ Mn) Forecast, by Region 9.3. Global Atopic Dermatitis Drugs Market Attractiveness Analysis, by Region 9.4. Key Trends 9.4.1. Key Developments 10. North America Atopic Dermatitis Drugs Market Analysis 10.1. North America Atopic Dermatitis Drugs Market Overview 10.2. North America Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 10.3. North America Atopic Dermatitis Drugs Market Forecast, By Therapy 10.3.1. Photo Therapy 10.3.2. Directed Therapy 10.4. North America Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 10.5. North America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.5.1. Injectable 10.5.2. Oral 10.5.3. Topical 10.6. North America Atopic Dermatitis Drugs Market Value Share Analysis, By End User 10.7. North America Atopic Dermatitis Drugs Market Forecast, By End User 10.7.1. Hospitals 10.7.2. Clinics 10.7.3. Research Labs 10.8. North America Atopic Dermatitis Drugs Market Value Share Analysis, by Country 10.9. North America Atopic Dermatitis Drugs Market Forecast, by Country 10.9.1. U.S. 10.9.2. Canada 10.10. North America Atopic Dermatitis Drugs Market Analysis, by Country 10.11. U.S. Atopic Dermatitis Drugs Market Forecast, By Therapy 10.11.1. Photo Therapy 10.11.2. Directed Therapy 10.12. U.S. Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.12.1. Injectable 10.12.2. Oral 10.12.3. Topical 10.13. U.S. Atopic Dermatitis Drugs Market Forecast, By End User 10.13.1. Hospitals 10.13.2. Clinics 10.13.3. Research Labs 10.14. Canada Atopic Dermatitis Drugs Market Forecast, By Therapy 10.14.1. Photo Therapy 10.14.2. Directed Therapy 10.15. Canada Atopic Dermatitis Drugs Market Forecast, By Route of Administration 10.15.1. Injectable 10.15.2. Oral 10.15.3. Topical 10.16. Canada Atopic Dermatitis Drugs Market Forecast, By End User 10.16.1. Hospitals 10.16.2. Clinics 10.16.3. Research Labs 10.17. North America Atopic Dermatitis Drugs Market Attractiveness Analysis 10.17.1. By Therapy 10.17.2. By Route of Administration 10.17.3. By End User 10.18. PEST Analysis 10.19. Key Trends 10.19.1. Key Developments 11. Europe Atopic Dermatitis Drugs Market Analysis 11.1. Europe Atopic Dermatitis Drugs Market Overview 11.2. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 11.3. Europe Atopic Dermatitis Drugs Market Forecast, By Therapy 11.3.1. Photo Therapy 11.3.2. Directed Therapy 11.4. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 11.5. Europe Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.5.1. Injectable 11.5.2. Oral 11.5.3. Topical 11.6. Europe Atopic Dermatitis Drugs Market Value Share Analysis, By End User 11.7. Europe Atopic Dermatitis Drugs Market Forecast, By End User 11.7.1. Hospitals 11.7.2. Clinics 11.7.3. Research Labs 11.8. Europe Atopic Dermatitis Drugs Market Value Share Analysis, by Country 11.9. Europe Atopic Dermatitis Drugs Market Forecast, by Country 11.9.1. Germany 11.9.2. U.K. 11.9.3. France 11.9.4. Italy 11.9.5. Spain 11.9.6. Rest of Europe 11.10. Europe Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 11.11. Germany Atopic Dermatitis Drugs Market Forecast, By Therapy 11.11.1. Photo Therapy 11.11.2. Directed Therapy 11.12. Germany Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.12.1. Injectable 11.12.2. Oral 11.12.3. Topical 11.13. Germany Atopic Dermatitis Drugs Market Forecast, By End User 11.13.1. Hospitals 11.13.2. Clinics 11.13.3. Research Labs 11.14. U.K. Atopic Dermatitis Drugs Market Forecast, By Therapy 11.14.1. Photo Therapy 11.14.2. Directed Therapy 11.15. U.K. Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.15.1. Injectable 11.15.2. Oral 11.15.3. Topical 11.16. U.K. Atopic Dermatitis Drugs Market Forecast, By End User 11.16.1. Hospitals 11.16.2. Clinics 11.16.3. Research Labs 11.17. France Atopic Dermatitis Drugs Market Forecast, By Therapy 11.17.1. Photo Therapy 11.17.2. Directed Therapy 11.18. France Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.18.1. Injectable 11.18.2. Oral 11.18.3. Topical 11.19. France Atopic Dermatitis Drugs Market Forecast, By End User 11.19.1. Hospitals 11.19.2. Clinics 11.19.3. Research Labs 11.20. Italy Atopic Dermatitis Drugs Market Forecast, By Therapy 11.20.1. Photo Therapy 11.20.2. Directed Therapy 11.21. Italy Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.21.1. Injectable 11.21.2. Oral 11.21.3. Topical 11.22. Italy Atopic Dermatitis Drugs Market Forecast, By End User 11.22.1. Hospitals 11.22.2. Clinics 11.22.3. Research Labs 11.23. Spain Atopic Dermatitis Drugs Market Forecast, By Therapy 11.23.1. Photo Therapy 11.23.2. Directed Therapy 11.24. Spain Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.24.1. Injectable 11.24.2. Oral 11.24.3. Topical 11.25. Spain Atopic Dermatitis Drugs Market Forecast, By End User 11.25.1. Hospitals 11.25.2. Clinics 11.25.3. Research Labs 11.26. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By Therapy 11.26.1. Photo Therapy 11.26.2. Directed Therapy 11.27. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By Route of Administration 11.27.1. Injectable 11.27.2. Oral 11.27.3. Topical 11.28. Rest of Europe Atopic Dermatitis Drugs Market Forecast, By End User 11.28.1. Hospitals 11.28.2. Clinics 11.28.3. Research Labs 11.29. Europe Atopic Dermatitis Drugs Market Attractiveness Analysis 11.29.1. By Therapy 11.29.2. By Route of Administration 11.29.3. By End User 11.30. PEST Analysis 11.31. Key Trends 11.31.1. Key Developments 12. Asia Pacific Atopic Dermatitis Drugs Market Analysis 12.1. Asia Pacific Atopic Dermatitis Drugs Market Overview 12.2. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 12.3. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Therapy 12.3.1. Photo Therapy 12.3.2. Directed Therapy 12.4. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 12.5. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.5.1. Injectable 12.5.2. Oral 12.5.3. Topical 12.6. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, By End User 12.7. Asia Pacific Atopic Dermatitis Drugs Market Forecast, By End User 12.7.1. Hospitals 12.7.2. Clinics 12.7.3. Research Labs 12.8. Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, by Country 12.9. Asia Pacific Atopic Dermatitis Drugs Market Forecast, by Country 12.9.1. China 12.9.2. India 12.9.3. Japan 12.9.4. ASEAN 12.9.5. Rest of Asia Pacific 12.10. Asia Pacific Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 12.11. China Atopic Dermatitis Drugs Market Forecast, By Therapy 12.11.1. Photo Therapy 12.11.2. Directed Therapy 12.12. China Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.12.1. Injectable 12.12.2. Oral 12.12.3. Topical 12.13. China Atopic Dermatitis Drugs Market Forecast, By End User 12.13.1. Hospitals 12.13.2. Clinics 12.13.3. Research Labs 12.14. India Atopic Dermatitis Drugs Market Forecast, By Therapy 12.14.1. Photo Therapy 12.14.2. Directed Therapy 12.15. India Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.15.1. Injectable 12.15.2. Oral 12.15.3. Topical 12.16. India Atopic Dermatitis Drugs Market Forecast, By End User 12.16.1. Hospitals 12.16.2. Clinics 12.16.3. Research Labs 12.17. Japan Atopic Dermatitis Drugs Market Forecast, By Therapy 12.17.1. Photo Therapy 12.17.2. Directed Therapy 12.18. Japan Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.18.1. Injectable 12.18.2. Oral 12.18.3. Topical 12.19. Japan Atopic Dermatitis Drugs Market Forecast, By End User 12.19.1. Hospitals 12.19.2. Clinics 12.19.3. Research Labs 12.20. ASEAN Atopic Dermatitis Drugs Market Forecast, By Therapy 12.20.1. Photo Therapy 12.20.2. Directed Therapy 12.21. ASEAN Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.21.1. Injectable 12.21.2. Oral 12.21.3. Topical 12.22. ASEAN Atopic Dermatitis Drugs Market Forecast, By End User 12.22.1. Hospitals 12.22.2. Clinics 12.22.3. Research Labs 12.23. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Therapy 12.23.1. Photo Therapy 12.23.2. Directed Therapy 12.24. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By Route of Administration 12.24.1. Injectable 12.24.2. Oral 12.24.3. Topical 12.25. Rest of Asia Pacific Atopic Dermatitis Drugs Market Forecast, By End User 12.25.1. Hospitals 12.25.2. Clinics 12.25.3. Research Labs 12.26. Asia Pacific Atopic Dermatitis Drugs Market Attractiveness Analysis 12.26.1. By Therapy 12.26.2. By Route of Administration 12.26.3. By End User 12.27. PEST Analysis 12.28. Key Trends 12.28.1. Key Developments 13. Middle East & Africa Atopic Dermatitis Drugs Market Analysis 13.1. Middle East & Africa Atopic Dermatitis Drugs Market Overview 13.2. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 13.3. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.3.1. Photo Therapy 13.3.2. Directed Therapy 13.4. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 13.5. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.5.1. Injectable 13.5.2. Oral 13.5.3. Topical 13.6. Middle East & Africa Atopic Dermatitis Drugs Market Value Share Analysis, By End User 13.7. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.7.1. Hospitals 13.7.2. Clinics 13.7.3. Research Labs 13.8. Middle East & Africa Atopic Dermatitis Drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 13.10. GCC Atopic Dermatitis Drugs Market Forecast, By Therapy 13.10.1. Photo Therapy 13.10.2. Directed Therapy 13.11. GCC Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.11.1. Injectable 13.11.2. Oral 13.11.3. Topical 13.12. GCC Atopic Dermatitis Drugs Market Forecast, By End User 13.12.1. Hospitals 13.12.2. Clinics 13.12.3. Research Labs 13.13. Others South Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.13.1. Photo Therapy 13.13.2. Directed Therapy 13.14. South Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.14.1. Injectable 13.14.2. Oral 13.14.3. Topical 13.15. South Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Research Labs 13.16. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Therapy 13.16.1. Photo Therapy 13.16.2. Directed Therapy 13.17. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By Route of Administration 13.17.1. Injectable 13.17.2. Oral 13.17.3. Topical 13.18. Rest of Middle East & Africa Atopic Dermatitis Drugs Market Forecast, By End User 13.18.1. Hospitals 13.18.2. Clinics 13.18.3. Research Labs 13.19. Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness Analysis 13.19.1. By Therapy 13.19.2. By Route of Administration 13.19.3. By End User 13.20. PEST Analysis 13.21. Key Trends 13.21.1. Key Developments 14. South America Atopic Dermatitis Drugs Market Analysis 14.1. South America Atopic Dermatitis Drugs Market Overview 14.2. South America Atopic Dermatitis Drugs Market Value Share Analysis, By Therapy 14.3. South America Atopic Dermatitis Drugs Market Forecast, By Therapy 14.3.1. Photo Therapy 14.3.2. Directed Therapy 14.4. South America Atopic Dermatitis Drugs Market Value Share Analysis, By Route of Administration 14.5. South America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.5.1. Injectable 14.5.2. Oral 14.5.3. Topical 14.6. South America Atopic Dermatitis Drugs Market Value Share Analysis, By End User 14.7. South America Atopic Dermatitis Drugs Market Forecast, By End User 14.7.1. Hospitals 14.7.2. Clinics 14.7.3. Research Labs 14.8. South America Atopic Dermatitis Drugs Market Value Share Analysis, by Country 14.9. South America Atopic Dermatitis Drugs Market Forecast, by Country 14.9.1. Brazil 14.9.2. Mexico 14.9.3. Rest of South America 14.10. South America Atopic Dermatitis Drugs Market Analysis, by Country/ Sub-region 14.11. Brazil Atopic Dermatitis Drugs Market Forecast, By Therapy 14.11.1. Photo Therapy 14.11.2. Directed Therapy 14.12. Brazil Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.12.1. Injectable 14.12.2. Oral 14.12.3. Topical 14.13. Brazil Atopic Dermatitis Drugs Market Forecast, By End User 14.13.1. Hospitals 14.13.2. Clinics 14.13.3. Research Labs 14.14. Mexico Atopic Dermatitis Drugs Market Forecast, By Therapy 14.14.1. Photo Therapy 14.14.2. Directed Therapy 14.15. Mexico Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.15.1. Injectable 14.15.2. Oral 14.15.3. Topical 14.16. Mexico Atopic Dermatitis Drugs Market Forecast, By End User 14.16.1. Hospitals 14.16.2. Clinics 14.16.3. Research Labs 14.17. Rest of South America Atopic Dermatitis Drugs Market Forecast, By Therapy 14.17.1. Photo Therapy 14.17.2. Directed Therapy 14.18. Rest of South America Atopic Dermatitis Drugs Market Forecast, By Route of Administration 14.18.1. Injectable 14.18.2. Oral 14.18.3. Topical 14.19. Rest of South America Atopic Dermatitis Drugs Market Forecast, By End User 14.19.1. Hospitals 14.19.2. Clinics 14.19.3. Research Labs 14.20. South America Atopic Dermatitis Drugs Market Attractiveness Analysis 14.20.1. By Therapy 14.20.2. By Route of Administration 14.20.3. By End User 14.21. PEST Analysis 14.22. Key Trends 14.22.1. Key Developments 15. Company Landscape 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Competitive Benchmarking of Company and Services 15.4. Company Profiles: Key Players 15.4.1. Mylan 15.4.1.1. Company Overview 15.4.1.2. Financial Overview 15.4.1.3. Business Strategy 15.4.1.4. Recent Developments 15.4.1.5. Development Footprint 15.4.2. LEO Pharma 15.4.3. Bayer HealthCare 15.4.4. Encore Dermatology 15.4.5. Novartis AG 15.4.6. Valent Pharmaceutical Inc. 15.4.7. Astellas Pharma Inc. 15.4.8. Meda AB 15.4.9. Bayer Ag 15.4.10. Encore Dermatology 16. Primary Key Insights